Name: SITC 2023 Insights: &quot;AI-Designed Personalized Neoantigen Vaccine, EVX-02, Induces Robust T-Cell Responses in Melanoma Patients&quot;
Uploaded: 2023-12-13T16:38:26.053180+00:00
Duration: 16 min 27 s
Description: SITC 2023 Insights: &quot;AI-Designed Personalized Neoantigen Vaccine, EVX-02, Induces Robust T-Cell Responses in Melanoma Patients&quot;